董培新
Molecular-targeted therapies and precision medicine for endometrial cancer
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor
Yue, Junming and Du, Ziyun and Zhou, Fu-Ming and Dong, Peixin and Pfeffer, Lawrence M「Applications of CRSIPR/Cas9 in Cancer Research」『Cancer Medicine & Anti Cancer Drugs』第1巻第1号、OMICS International、2016年3月、1000103頁、NAID 120005752854。
Restoration of tumor suppressor miRNAs: The loss or down-regulation of a tumor suppressor miRNA could be overcome by the restoration of these silenced miRNAs.
Blocking oncogenic miRNAs: Another strategy to target miRNA expression in cancer is to block the expression of an oncogenic miRNA.
CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy.
Interconnection between EMT and stemness in gynecological cancers.
miRNAs regulates endometrial cancer metastasis through modulating tumor microenvironment.